Article
Beyond HLA: An adaptive nanopore sequencing assay for simultaneous HLA and blood group profiling in transplantation.
Human immunology - 1 May 2026
Grasedieck S, McIntyre L, Roulis E, Hamadeh Z, Murphey C, Lane W J, Keown P A, Sherwood K R
Abstract excerpt
AIM: Transplantation is a life-saving therapy but carries significant risks, including rejection, graft-versus-host disease, infection, and malignancy, which can lead to graft failure and death. These complications arise from the interaction between the recipient's immune system and the transplanted organ, requiring long-term toxic drugs to prevent immune injury. Traditional genetic pre-transplant assessment...
Topics
- Humans
- HLA Antigens
- Nanopore Sequencing
- Histocompatibility Testing
- Graft Rejection
- Genotype
- Blood Grouping and Crossmatching
- Organ Transplantation
